The primary targets identified were EGFR, MAPK1, MAPK14, AKT1, CASP3, and PRKACA, and ginseng and its constituents may have therapeutic promise for Alzheimer's disease. Here, EGFR is linked to early-onset autosomal dominant Alzheimer disease.